These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6830109)

  • 1. [Significance of fibrin fibrinogen degradation products in the cerebrospinal fluid in the neonatal period].
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Ann Pediatr (Paris); 1983 Jan; 30(1):59-62. PubMed ID: 6830109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Signification of fibrinogen degradation (FDP) product in CSF during the neonatal period (author's transl)].
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Pathol Biol (Paris); 1981 Dec; 29(10):605-8. PubMed ID: 7041056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen degradation products in human CSF: a preliminary clinical study].
    Li YP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):142-5. PubMed ID: 3757627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinogen degradation products in the cerebrospinal fluid in central nervous system diseases].
    Kolanowska H; Solecka B
    Pol Przegl Chir; 1980 Aug; 52(8):729-34. PubMed ID: 7433284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological evaluation of neonatal brain damage].
    Dalens B; Bezou MJ; Viallard JL; Raynaud EJ; Coulet M; Dastugue B; Haberer JP
    Pediatrie; 1981; 36(7):527-38. PubMed ID: 7322766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases (author's transl)].
    Maruyama I; Igata A
    Rinsho Shinkeigaku; 1979 Aug; 19(8):481-5. PubMed ID: 498662
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinogen degradation products (FDP) in purulent cerebrospinal meningitis in children].
    Myśliwiec B
    Pol Tyg Lek; 1978 Jul; 33(31):1213-5. PubMed ID: 693393
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinogen degradation products in the cerebrospinal fluid of children with lymphoblastic leukemia].
    Borkowski W; Kolanowska H; Depowska T; Kaczor Z
    Pediatr Pol; 1981 Sep; 56(9):1017-20. PubMed ID: 6948264
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin-fibrinogen degradation products in cerebrospinal fluid as an indicator of neonatal brain damage.
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Acta Neurol Scand; 1981 Aug; 64(2):81-7. PubMed ID: 7324879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia].
    Suzuki S; Graeff H; Hafter R
    Arch Gynecol; 1979 Jul; 228(1-4):626-7. PubMed ID: 485520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of electrophoretic studies of the cerebrospinal fluid in neuropediatric diagnosis].
    Geissler W
    Padiatr Grenzgeb; 1983; 22(1):15-25. PubMed ID: 6866526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrin(ogen degradation product concentration (SFP) as a diagnostic parameter for the differentiation of artifical and essential blood in cerebrospinal fluid].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jan; 30(1):36-9. PubMed ID: 643973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen, fibrinogen degradation products and fibrinolytic activity in cerebrospinal fluid in stroke.
    Dube RK; Sahaa PK; Dube B; Katiyar BC; Rao PV
    Indian J Med Res; 1980 Sep; 72():454-7. PubMed ID: 7461776
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoglobulins A, M and G, fibrinogen degradation products (FFDP) and alkaline phosphatase activity in the cerebrospinal fluid in differential diagnosis of meningitis in children].
    Rudobielska M; Szafrańska M; Zoch-Zwierz W; Myśliwiec B
    Pol Tyg Lek; 1980 Aug; 35(34):1293-5. PubMed ID: 7443556
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients with meningococcal infections (author's transl)].
    Bajo R; Vaca R; Elduayen R; Zarallo L; Cardesa JJ; Pérez-Miranda M
    Med Clin (Barc); 1980 Nov; 75(8):338-41. PubMed ID: 7442335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal fluid clotting activity: a new method of evaluating neonatal brain damage.
    Dalens B; Bezou MJ; Coulet M; Haberer JP; Vanneuville G
    Pediatr Res; 1982 Jun; 16(6):412-5. PubMed ID: 7099757
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):465-73. PubMed ID: 144927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of fibrin-fibrinogen degradation products (FFDP) in the diagnosis of meningitis in children].
    Myśliwiec B
    Pediatr Pol; 1980 Apr; 55(4):421-6. PubMed ID: 7413304
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of serum and synovial fluid fibrin degradation products (FDP) estimation in rheumatoid arthritis.
    Gulati PD; Sood KC; Saha K; Kumar A; Zizvi SN
    J Assoc Physicians India; 1982 Nov; 29(11):903-6. PubMed ID: 7130107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of fibrinogen degradation products by rocket immunoelectrophoresis].
    Zozuliakova SV; Podosinnikov IS
    Lab Delo; 1981; (7):409-11. PubMed ID: 6167774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.